PMEL and melanoma: Immunotherapy may be used for tumors because they express tumor associated antigens (82,83); melanoma lesions often contain a high number of infiltrative T-cells specific to melanocyte tumor-associated antigens such as MART1, gp100 and tyrosinase (84).